News | Radiation Dose Management | May 02, 2016

SCAI Eye Exams for Interventional Cardiologists Helps Track Radiation Exposure

Effort to track radiation exposure impact on cath lab staff begins at SCAI 2016

radiation dose in the cath lab

May 2, 2016 — Starting at the Society for Cardiovascular Angiography and Interventions (SCAI) 2016 annual meeting May 4-6, SCAI will begin efforts to collect real data on the impact of radiation-induced cataracts amongst the cardiovascular cath lab team.

Through the IC-CATARACT initiative led by Manos Brilakis, M.D., Ph.D., FSCAI, and his team of researchers from VA North Texas Healthcare System and UT Southwestern Medical Center, will offer free eye exams at the SCAI meeting in the IC-CATARACT suite in the exhibit hall. 

The full extent of these radiation risks is not yet known and SCAI is starting this effort to focus on the well-being and health of its members. The society will be focusing on workplace issues in the coming year. 

Support of this initiative provided by Dallas VA Research Corp.

On the morning of Thursday, May 5, the SCAI Quality Track will focus on safety in the cath lab as well with two morning sessions, “Interventional Medicine: Occupational Hazards? You Bet Your Life,” and Minimizing Occupational Hazards of Interventional Medicine: Tips and Tricks.”

For more information: www.scai.org/SCAI2016/Detail.aspx?cid=6360c846-1b75-4a48-b28e-d98710b122c8

Related Content

Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Marijuana Associated With Three-Fold Risk of Death From Hypertension
News | Hypertension| September 14, 2017
Marijuana use is associated with a three-fold risk of death from hypertension, according to research published recently...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
Overlay Init